Bellevue Life Sciences Ac...

AI Score

0

Unlock

11.40
0.06 (0.53%)
At close: Jan 03, 2025, 9:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income 403.78K -35.39K -3.31K -23.81K
Depreciation & Amortization n/a n/a n/a n/a
Stock-Based Compensation n/a n/a n/a n/a
Other Working Capital 517.35K 31.15K 2.85K n/a
Other Non-Cash Items -2.78M n/a n/a n/a
Deferred Income Tax n/a n/a n/a n/a
Change in Working Capital 1.55M 31.15K 2.85K n/a
Operating Cash Flow -818.77K -4.24K -461 -23.81K
Capital Expenditures -4 n/a n/a n/a
Acquisitions n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a
Other Investing Acitivies -33.83M n/a n/a n/a
Investing Cash Flow -33.83M n/a n/a n/a
Debt Repayment -1.20M 800.00K 100.00K n/a
Common Stock Repurchased -36.00M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies 7.77M -676.02K 10.00K 86.47K
Financial Cash Flow 34.54M 123.98K -57.44K 86.47K
Net Cash Flow -109.08K 119.74K -57.90K 62.65K
Free Cash Flow -818.77K -4.24K -461 -23.81K